VIVET THERAPEUTICS ATTENDING JEFFERIES 2025 – LONDON HEALTHCARE CONFERENCE
Vivet Therapeutics is pleased to announce that our CEO, Jean-Philippe Combal, will be attending the Jefferies Global Healthcare Conference in London from November 18th to 20th, 2025. As we join this leading global event, we are excited to present our latest advances, including the VTX-PID NAb depleting strategy. VTX-PID is designed to temporarily reduce anti-AAV […]
Join our CEO, @Jean-Philippe Combal in the BigApple for @Chardan’s 9th Annual Genetic Medicines Conference!
Join our CEO, @Jean-Philippe Combal in the Big Apple for @Chardan’s 9th Annual Genetic Medicines Conference! The premier event will bring together groundbreaking thought leaders to discuss major themes in genetic medicines through fireside chats, individual company presentations, one-on-one meetings, and panel discussions . Get in touch if you would like to connect with Jean-Philippe […]
Two poster presentations at ESGCT 2025 in Sevilla
Vivet Therapeutics is excited to announce two poster presentations at ESGCT 2025 in Sevilla, showcasing innovative advances in liver-directed gene therapy. Catch us on Thursday, October 9th, from 14:00 to 15:30 CEST:
ESGCT Sevilla
Vivet Therapeutics is delighted to announce its participation in the European Society of Gene & Cell Therapy (ESGCT) Annual Congress, taking place in Sevilla, on October 7–10, 2025 (https://www.esgctcongress.com). On Thursday, October 9, Vivet will present new data on VTX-PID, highlighting compelling clinical results that demonstrate a reduction of neutralizing antibodies against AAV in naturally immunized populations. These findings have […]
Vivet Therapeutics is heading west for The Liver Meeting in sunny ☀ San Diego, California!
📢 @Vivet Therapeutics is heading west for The Liver Meeting in sunny ☀ San Diego, California! ⛱ Listen in as #Vivet’s Co-founder & Chief Scientific Officer, Dr @Gloria Gonzalez-Aseguinolaza presents 🎤 key findings on #VTX-806, our gene therapy program for Cerebrotendinous Xanthomatosis (#CTX) at The Liver Meeting (#TLM) presented by the @American Association for the […]
🎉 Vivet Therapeutics is heading to Stockholm for BIO-Europe! 🎉
Join our Co-Founder & Chief Executive Officer, @Jean-Philippe Combal, and @Susan Coles, General Counsel and Head of Finance at #BIOEurope2024 in Stockholm, Sweden from 4-6 November. Don’t miss the opportunity to connect 🤝with Jean-Philippe and Susan to learn more about #Vivet’s disruptive development engine and its diversified pipeline. Celebrating its 30th year, #BIOEurope, presented by […]
Australasian Gene & Cell Therapy Biennial Meeting
📣#VivetTherapeutics is headed to the land down under!📣 Join our Co-Founder and CSO, Dr @Gloria Gonzalez-Aseguinolaza at the Australasian Gene and Cell Therapy Society (#ASGCT) Biennial Meeting in Sydney, Australia from 30 October – 1 November. Don’t miss this excellent opportunity to listen👂in as Gloria provides insight into gene editing for the treatment of inherited […]
Inaugural Cell & Gene Therapy Regulatory Affairs Summit presented by @HansonWade, from 28 – 30 October in 🏦 Washington, D.C.!
Connect with Co-Founder & CEO, @Jean-Philippe Combal & Director of Regulatory Affairs & Quality Assurance, @Annelise Brossel at the inaugural Cell & Gene Therapy Regulatory Affairs Summit presented by @HansonWade, from 28 – 30 October in 🏦 Washington, D.C.! Get in touch to schedule a meeting with the team or you can find Jean-Philippe and […]
Who’s excited about the @World Orphan Drug Congress Europe 2024🌍taking place in Spain from 22-25 October?
With over 25 years of expertise in #drugdevelopment, our Head of Clinical Operations & Patient Advocacy Representative, @Sonia Valero, will join industry leaders on a panel 📢 to share valuable insights on the “Convergence on Rare Disease and Precision Medicine – a Real Drive on Drug Development.” 📅 Date: Wednesday 23rd October 2024 🕘 Time: […]
🎓Are you attending the upcoming 2024 @European Society of Gene and Cell Therapy (#ESGCT) Congress, from 22-25 October in Rome, Italy?
Don’t miss the opportunity to meet the @Vivet Therapeutics leadership team who will be participating in a jam-packed schedule at the event. 👂Listen in as our Co-Founder and CSO, Dr @Gloria Gonzalez Aseguinolaza deliberates on the latest developments in gene therapy for liver disease in an oral presentation and panel discussion. Also check out our […]
